🔎 Trials Near Me

Home › Prostate Cancer › Connecticut › Stamford

Prostate Cancer clinical trials in Stamford, CT

5 studies for Prostate Cancer are looking for participants at sites in and around Stamford (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • Northwell Health Cancer Institute at Huntington, Greenlawn · 16 mi away
  • Northwell Health Imbert Cancer Center, Bay Shore · 27 mi away
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

RecruitingPhase 2
  • Stamford Hospital/Bennett Cancer Center, Stamford
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06632977

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

RecruitingPhase 3
  • Northwell Health Imbert Cancer Center, Bay Shore · 27 mi away
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

RecruitingPhase 2
  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich · 5 mi away
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RecruitingPhase 3
  • Stamford Hospital/Bennett Cancer Center, Stamford
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Stamford

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.